Latest filing published 22 Dec 2025 for Tivic Health Systems, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Jennifer Ernst: trading record in brief
This profile gathers the share dealings of Jennifer Ernst in Valion Bio, Inc., where the filings describe the role as chief executive. Between 12 November 2021 and 18 December 2025, the trades on record add up to 5 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 22 December 2025: a share grant of €8,380, in Valion Bio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jennifer Ernst
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 14,706 sharesCommon StockSEC:0001683168-25-009305:0
- 22,541 shares0Common StockSEC:0001683168-25-007223:0
- 1,391 shares0Common StockSEC:0001104659-21-139507:0
3 of 3 declarations